EU commission recognises failure in innovation

“A mismatch still remains between public health needs (e.g. treatments for Alzheimer’s) and where industry chooses to invest (many ‘me-too drugs’)….Mobilising the necessary critical mass of knowledge and financial resources can only be undertaken at the EU level”

http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=SWD:2013:0245:FIN:EN:PDF

Proposal for a Council Regulation on the Innovative Medicines Initiative 2 Joint Undertaking:– 10.7.2013

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s